# OnCo record checkmate-141 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/checkmate-141/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "checkmate-141", "NCT02105636" ;
  schema:name "CheckMate 141"@en ;
  schema:description "The first immunotherapy to extend survival in head and neck cancer, in patients who had progressed on platinum within six months."@en ;
  schema:url <https://onco.cc/trials/checkmate-141/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02105636>, <https://www.nejm.org/doi/full/10.1056/NEJMoa1602252> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2014-05-29" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/oropharyngeal-cancer/>, <https://onco.cc/cancers/oral-cavity-cancer/>, <https://onco.cc/cancers/recurrent-metastatic-hnscc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/> .